Publications

• Alberts DS, Markman M, Armstrong D, Rothenberg ML, Muggia F, Howell SB. Intraperitoneal therapy for stage III ovarian cancer: A therapy whose time has come! J Clin Oncol.2002;20:3944-3946.
• Alvarez JG, Sharma RK, Ollero M, Saleh RA, Lopez MC, Evenson D, Agarwal A. Increased DNA damage in sperm from leukocytospermic semen samples as determined by the sperm chromatin structure assay (SCSA). Fertil Steril.2002;78:319-329.
• Attaran M, Goldberg J, Falcone T. Endometriosis: still tough to diagnose and treat. Cleveland Clinic J Med. 2002;69:647-653.
• Barakat RR, Sabbatini P. Bhaskaran D. Revzin M, Smith A, Venkatraman E, Aghajanian C, Hensley M, Soignet S, Brown C, Markman M, Hoskins WJ, Spriggs D. Intraperitoneal chemotherapy for ovarian carcinoma: Results of long-term follow-up. J Clinic Oncol.2002;20:694-698.
• Barakat RR, Greven KM, Markman M. Endometrial Cancer. In: Pazdur R, Coia LR, Hoskins WJ, Wagman LD (eds). Cancer Managemernt: A Multidisciplinary Approach. Sixth Edition. New York, PPP Inc. 2002: Chapter 21, p 419-438.
• Barber MD, Bremer R, Thor K, Dolber P, Kuehl T, Coates K. Innervation of female levator ani muscles. Am J Opstat Gynecol.2002;187:64-71.
• Barber MD. Commentary: Tolterodine was effective and well tolerated for short-term treatment of urge incontinence. Evidence Based Obstet Gynecol.2002;4:199-200.
• Barrett JP, Whiteside JL, Boardman L. Clostridial sepsis following spontaneous abortion. Obstet Gynecol.2002;99:899-901.
• Batur P, Thacker HL, Moore HC. Discussing breast cancer and hormone replacement therapy with women. Cleve Clin J Med.2002;69(11):838-848.
• Baudhuin LM, Kristina KL, Lu, J, and Xu Y. Activation induced by LPA and S1P requires both MEK and p38 MAP kinase and is cell-line specific. Mol Pharmacol 62, 660-671, 2002.
• Bedaiwy, M.A., Falcone T., Goldberg, J., Sharma, R.K. Oxidative stress may have an influence on the effectiveness of IVF. Hum. Reprod. 2002 17: 2780.
• Bedaiwy MA, Falcone T, Sharma RK, Goldberg JM, Attaran M, Nelson DR, Agarwal A. Prediction of endometriosis with serum and peritoneal fluid markers: A prospective controlled trial. Hum Reprod. 2002;17:426-431.
• Bedaiwy MA, Goldberg JM, Falcone T, Singh M, Nelson DR,Azab H, Wang X, Sharma RK. Relationship between oxidative stress and embryotoxicity of Hydrosalpingeal fluid. Hum Reprod 2002; 17: 601-604.
• Belinson JL, Pan QJ, Biscotti C, Pretorius RG, Elson P, Qiao YL. Primary Screening with Liquid Based Cytology in a High Risk Unscreened Population. ACTA Cytologica.
  May/June 2002: 46: 470-474.
• Bloss JD, Blessing HA, Behrens BC, Mannel RS, Rader JS, Sood AK, Markman M, Benda J. Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: A Gynecologic Oncology Group study. J Clin Oncol.2002;20:1832-1837.
• Bradley LD, Complications in Hysteroscopy:Prevention, Treatment and Legal Risk. Curr Opinion Obstet Gynecol.2002;14(1): 409-415.
• Church J, Burke C, McGannon E, Pastean O, Clark B. Predicting polyposis severity by proctoscopy: how reliable is it? Dis Colon Rectum. 2002; 44(9):1249-1254.
• Cogan SL, Paraiso MF, Bedaiwy M. Formation of vesicovaginal fistulas in laparoscopic hysterectomy with electrosurgical-induced cystotomy in female mongrel dogs. Am J Obstet Gynecol.2002;187(6):1510-1514.
• Desai N, Kattal, N, Abdel-Hafez F, Szeptycki J. 2007. Granuolocyte-macrophage colony stimulating factor (GM-CSF) and co-culture can affect development and apoptosis in cryopreserved embryos. Journal of Assisted Reproduction and Genetics. Accepted for publication Feb 2007
• Desai N, Blackmon H, Szeptycki J, Goldfarb J. Cryoloop vitrification of human day 3 cleavage-stage embryos: post-vitrification development, pregnancy outcomes and live births. Reprod Biomed Online. 2007 Feb;14(2):208-13
• Desai N, Filipovitz, J and Goldfarb, J. 2006. Secretion of sHLA-G by Day 3 human embryos associated with higher pregnancy and implantation rates:assay of culture media using a new ELISA kit. Manuscript submitted by RBM Online
• Desai,N. The road to blastocyst transfer. 1998. Human Reproduction13:3292 - 3294. . Also Internet Webtrack publication
• Desai N. Uniquely selected day-3 vs highly selected day-5 paired embryos implant comparably. The Embryologists ' Newsletter, Winter 2002.
• Desai, N., Austin, C, Peskin, B., Lisbona,H and Goldfarb, J. 2002. Uniquely selected Day-3 vs highly elected Day-5 embryos implant comparably. The Embryologist Newsletter, 2002.
• Desai N, Blackmon,H and Goldfarb, J. 2004. Single sperm cryopreservation on cryoloops: an alternative to hamster zona for freezing individual spermatozoa. Reproductive BioMedicine Online 9:47-53; RBM Online
• Desai N, Filipovitz, J and Goldfarb, J. 2006. Secretion of sHLA-G by Day 3 human embryos associated with higher pregnancy and implantation rates:assay of culture media using a new ELISA kit. Manuscript submitted by RBM Online
• Desai, N and Goldfarb, J 1998. Cocultured human embryos may be subjected to widely different microenvironments: Quantification of growth factor and cytokine secretion during Vero cell coculture. Human Reproduction. 13 (6) 1600-1606
• Desai N, and Goldfarb, J. 2005. Examination of frozen cycles with replacement of a single thawed blastocyst. Reprod Biomed Online. 2005 Sep;11(3):349-54.
• N. Desai and J. Goldfarb. 1996. Growth factor/cytokine secretion by a permanent human endometrial cell line with embryotrophic properties. J. Assist. Reprod. Gen. 13(7):546 - 550.
• Desai NN, Goldstein J, Rowland DY, Goldfarb JM. 2000. Morphological evaluation of human embryos and derivation of an embryo quality scoring system specific for day 3 embryos: a preliminary study. Hum Reprod. 15(10):2190-6.
• N. Desai, E. Kennard, D. Kniss, C. Friedman. 1994. Novel human endometrial cell line promotes blastocyst development. Fertil. Steril. 61 (4) 760-766.
• Desai N, Kinzer D, Loeb A, Goldfarb J. 1997. Use of Synthetic Serum Substitute and alpha-minimum essential medium for the extended culture of human embryos to the blastocyst stage. Hum Reprod. 12(2):328-35.
• Desai N, Lawson, J and Goldfarb, J. 2000. Assessment of growth factor effects on post-thaw development of cryopreserved morula to the blastocyst stage. Hum. Reprod. 15 (2)410-418.
• Desai, N, Scarrow, M., Lawson, J., Kinzer, D., and Goldfarb, J. 1999. Evaluation of the effect of interleukin-6 and human extracellular matrix on embryonic development. Hum . Reprod. 14(6) 1599-1592.
• Duepree HJ, Senagore AJ, Delaney CP, Marcello PW, Brady KM, Falcone T. Laparoscopic resection of deep pelvic endometriosis with rectosigmoid involvement. J Am Coll Surgeons.2002;195:754-758.
• Esfandiari, N., Saleh, R.A., Blaut, A.P., Sharma, R.K., Nelson, D.R., Thomas, A.J., Jr., Falcone, T., and Agarwal, A. (2002): Effects of temperature on sperm characteristics and reactive oxygen species production. Int J Fertil & Women's Med. 2002;47:227-233.
• Falcone T, Bedaiwy MA. Minimally invasive management of uterine fibroids. Curr Opin Obstet Gynecol.2002;14:401-408.
• Falcone T. Infertility. An online chapter for the Disease Management textbook of the Cleveland Clinic Foundation for Continuing Education and the Unitech Communications. www.clevelandclinicmeded.com/diseasemanagement. March 2002.
• Falcone T. Laparoscopic Hysterectomy. An online chapter for WebSurg. 2002
• Falcone T, Steiner CP. Robotically-Assisted Gynecologic Surgery. Human Fertility 2002;5:72-4.(review)
• Falcone T. Laparoscopic surgery is not inherently dangerous for patients presenting with benign gynecologic pathology. Results of a meta-analysis. Evidence-based Obstetrics & Gynecology 2002;4:185-6.(comment)
• Gill I, Cherullo EE, Meraney AM, Borsuk F, Murphy DP, Falcone T. Vaginal extraction of the intact specimen following Laparoscopic radical nephrectomy. J Urol 2002;167:238-241.
• Goldberg J. Fostering fertility despite ovarian hyperstimulation syndrome. Obstet Gynecol Management. 2002;14:54-71.
• Goldfarb JM, Austin C, Peskin B, Lisbona H, Desai N, de Mola JR. 2000. Fifteen years experience with an in-vitro fertilization surrogate gestational pregnancy programme.Hum Reprod.15(5):1075-8.
• Goldfarb JM, Desai N. 2003 Clinical experience reported as a retrospective study. Fertil Steril. Nov;80(5):1123.
• Goldfarb JM, Desai N. 2003. Follitropin-alpha versus human menopausal gonadotropin in an in vitro fertilization program. Fertil Steril. Nov;80(5):1094-9.
• Goldfarb JM, Desai N. 2002. The spectrum of embryo transfer days. Fertil Steril.78(4):887;
• Jeremias E, Bedaisy MA, Gurunluoglu R, Biscotti CV, Siemionow, Falcone T. Heterotopic autotransplantation and vascular anastomosis: a novel surgical technique. Fertil Steril.2002;77:1278-1282.
• Kabarowski JH, Xu Y, Witte ON. Lysophosphatidylcholine as a ligand for immunoregulation. Biochem Pharmacol 64,161-167. 2002.
• Levine DA, Barakat RR, Sabbatini PJ, Bhaskaran D, Rizvin M, Smith A, Aghajanian CA, Hensley ML, Soignet SL, Brown CL, Markman M. Spriggs DR. Outcome after intraperitoneal chemotherapy for stage IV epithelial ovarian carcinoma. Gynecol Oncol.2002;84:509.
• Lu J, Baudhuin LM, Hong G, and Xu, Y. Role and Signaling Pathways of Ether-linked Lysophosphatidic Acids in Ovarian Cancer Cells. J. Lipid Res. 43, 463-476, 2002.
• Markman M. A patient with platinum-resistant ovarian cancer treated with liposomal doxorubicin. Case Studies in Ovarian Cancer.2002. Volume 1.
• Markman M. Assessing cancer clinical trials: Will your patient benefit from a "breakthrough?" Cleve Clin J Med.2002;69(5):368-376.
• Markman M. Second-line treatment of ovarian cancer with single-agent gemcitabine. Semin Oncol.2002;29:9-10.
• Markman M. Role of chemotherapy in the management of ovarian cancer. Expert Rev Anticancer Ther.2002;2(1):90-96.
• Markman M. Current status of cytotoxic drug treatment of epithelial ovarian cancer. CME J Gynecol Oncol.2002;7:5-9.
• Markman M. Progress in preventing chemotherapy-induced nausea and vomiting. Cleve Clin J Med. 2002;69(8)609-616.
• Markman M. Single agent carboplatin is the treatment of choice in recurrent, potentially platinum-sensitive ovarian cancer. Am Soc Clin Oncol Education Book, 38th Annual Meeting, 2002;521-523.
• Markman M. A case for consolidation therapy in ovarian cancer. Women's Oncol Rev. 2002;1:115-116.
• Markman M. Safety issues in using complementary and alternative medicine. J Clin Oncol.2002;20(18s):39s-41s.
• Markman M. Screening of common malignancies: A practical guide. In: Aziz K. Wu GY (eds), Cancer Screening: A Practical Guide for Physicians. Totowa NJ, Humana Press.2002; Chapter 1, p. 3-10.
• Markman M. Supportive Care. In: Giaccone G, Schilsky R, Sondel P (eds). Cancer Chemotherapy and Biologic Response Modifiers. Annual 20. Amsterdam, Elsevier Science Publishers. 2002. Chapter 30, p. 627-632.
• Markman M. Does palliative chemotherapy palliate? Curr Oncol Reports.2002;4:361.
• Markman M. Hypersensitivity reactions to carboplatin. Gynecol Oncol. 2002;84:353-354.
• Markman M. The use of PET scanning in ovarian cancer. Gynecol Oncol. 2002;85:391-392.
• Markman M. The prophylactic administration of recombinant erythropoietin in the management of ovarian cancer: Time for a phase 3 randomized trial. Gynecol Oncol.2002;86:237-238.
• Markman M, Bundy BN, Alberts DS, Fowler M, Clark-Pearkson DL, Carson LF, Wadler S, Sickel J. Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage II ovarian carcinoma: An intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group. Classic Papers and Current Comments: Highlights of Gynecologic Cancer Research.2002;7(1):92-99.
• Markman M, Hall J, Spitz D, Weiner S, Carson L, Van Le L, Baker M. Phase II trial of weekly single-agent paclitaxel in platinum/paclitaxel-refractory ovarian cancer. J Clin Oncol. 2002;20(9):2365-2369.
• Markman M, Kulp B, Peterson G, Kennedy A, Belinson J. Second-line therapy of ovarian cancer with paclitaxel administered by both the intravenous and intraperitoneal routes: Rationale and case reports. Gynecol Oncol 2002;86:95-98.
• Markman M. Liu PY, Wilczynski S, Monk BJ, Copeland L, Alberts D. Phase 3 randomized trial of 12 versus 3 months of single-agent paclitaxel in patients with advanced ovarian cancer who attained a clinically defined complete response to platinum/paclitaxel-based chemotherapy. A Southwest Oncology Group and Gynecologic Oncology Group Trial. Gynecol Oncol.2002;84:479.
• Markman M, Pederson G, Kulp B, Markman M. Effectiveness of serotonin-receptor antagonist antiemetic therapy over successive courses of carboplatin-based chemotherapy. Gynecol Oncol 2002;85:435-437.
• Markman M, Rose P, Kennedy A, Webster K, Zanotti K, Belinson J. Phase II trial of carboplatin, paclitaxel, and irinotecan in ovarian cancer and primary cancer of the peritoneum. Cancer Invest 2002: 20(suppl 1): 37-38.
• Markman M, Rothman R, Hakes T, Reichman B, Hoskins W, Rubin S, Jones W, Almadrones L, Lewis JL Jr. Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin. Classic Papers and Current Comments: Highlights of Gynecologic Cancer Research.2002;7(1)115-119.
• Markman M. Gynecologic, Prostate and Testicular Cancers. In: Stoller JK, Ahmad M, Longword DL (eds). The Cleveland Clinic Intesnive Review of Internal medicine. Third Edition. Philadelphia. Lippincott, Williams & Wilkins. 2002. Chapter 22, p 290-295.
• Mekhail T, Markman M. Acanthosis nigricans with endometrial carcinoma: Case report and review of the literature. Gynecol Oncol.2002;84:332-334.
• Makhail T, Markman M. Paclitaxel in cancer therapy. Expert Opinion in Pharmacotherapy. 2002;3(6):755-766.
• Messinger-Rapport BJ, Thacker HL. Prevention for the older woman, part 3: A practical guide to managing osteoporosis. Geriatrics.2002;57(4):16-27.
• Messinger-Rapport BJ, Thacker HL. Prevention for the older woman, part 4: A practical guide to managing cardiovascular disease. Geriatrics.2002;57(7):22-30.
• Messinger-Rapport BJ, Thacker HL. Prevention for the older woman, part 5: A practical guide to managing risk of malignancies. Geriatrics.2002;57(10):42-44.
• Myers ER, Barber MD, Couchman GL, Gusilo-Ashby T, Matchar DB, McCrory DC. Management of uterine leiomyomata: what do we really know? Obstet Gynecol.2002;100:80-17???
• Ozols RF, Markman M, Thigpen JT. ICON3 and chemotherapy for ovarian cancer. Lancet.2002.360:2086-2087.
• Paraiso MF. Surgery for vaginal apex prolapse. Curr Womens Health Rep.2002;Aug 2(4):285-290.
• Paraiso MF, Muir TW, Sokol A. Are midurethral slings the gold standard surgical treatment for primary genuine stress incontinence? J Am Assoc Gynecol Laparosc. 2002;9(4):405-407.
• Plaxe SC, Blessing JA, Husseinzadeh N, Webster K, Rader JS, Dunton CJ. Trial of pyrazoloacridine (PZA) in patients with persistent or recurrent endometrial carcinoma: A Gynecologic Oncology Group Study. Gynecol Oncol.2002;84(2): pages????
• Ranganathan, P., Mahran, A.M., Hallak, J., and Agarwal, A. Sperm cryopreservation for men with nonmalignant, systemic diseases: a descriptive study. J Androl.2002;23:71-75.
• Rose PG, Markman M, Bell J. A phase I study of sequential prolonged oral topotecan and prolonged oral etoposide as second-line therapy in ovarian, peritoneal, or tubal carcinoma. Gynecol Oncol. 2002;84:509.
• Saleh, R.A., Agarwal, A., Nelson, D.R., Nada, E.A., El-Tonsy, M.H., Alvarez, J.G., Thomas, A.J., Jr., and Sharma, R.K. (2002): Increased sperm nuclear DNA damage in normozoospermic infertile men: a prospective study. Fertil Steril 78:313-318.
• Saleh RA, Agarwal A, Sharma RK, Nelson DR, Thomas AJ Jr. Effect of cigarette smoking on levels of seminal oxidative stress in infertile men: A prospective study. Fertil Steril .2002;78:491-499.
• Saleh RA and Agarwal A. Oxidative stress and male infertility: From research bench to clinical practice. Review Article. J Androl.2002; 23:737-752.
• Saleh RA, Agarwal A, Kandirali E, Sharma RK, Thomas AJ Jr., Nada EA, Evenson DP, Alvarez JG. Leukocytospermia is associated with increased reactive oxygen species production by human sperm. Fertil Steril .2002;78:1215-1224.
• Sawatsri,S, Desai, N, Rock, J and Sidell, N. 2000. Retinoic acid suppresses interleukin-6 production in human endometrial cells. Fertil Steril.73(5):1012-9.
• Seftel, A, Rutchik,S, Chen, H, Stovsky,M , Goldfarb, J. and Desai, N. 1997. Effects of sublingual varicocoele ligation on sperm concentration, motility and Kruger morphology. J. Urology.158(5): 1800-1803. '
• N. Sheth-Desai and A. Eichholz. 1987. Organ-specific effects of 1, 2-dimethylhydrazine in hamster Epithelium. Jpn. J. Cancer Res (GANN) 78: 117-125.
• Smith T, Daneshgari G, Dmochowski R, Ghoniem G, Jarvis G, Nitti V, Paraiso MF. Surgical Treatment of Incontinence in Women. In Incontinence, from the 2nd International Consultation on Incontinence, 2nd edition. Plymouth Distributors Ltd, Plymouth, England, 2002.
• Smith S, Richards W, Caito K, Hanjani P, Markman M. DeGeest K. Gallion H. BRCA1 germline mutations and polymorphisms in a clinic-based series of ovarian cancer cases: A Gynecologic Oncology Group study. Gynecol Oncol.2002;83:586-592.
• Sprung J, Whalley DG, Falcone T, Warner, Hubmayr RD, Hammel J. The impact of morbid obesity, pneumoperitoneum, and posture on respiratory system mechanics and oxygenation during laparoscopy. Anesthesia & Analgesia. 2002;94:1345-50.
• Weber AM, Taylor RJ, Wei JT, Lemack G, Peidmonte MR, Walters MD. Cost-effectiveness of preoperative testing for stress urinary incontinence in women. BJU International.2002;89:356-363.
• Whiteside JL, Walters MD. Urinary incontinence: an overview and its relation to female genital tract tumors. CME J Gynecol Oncol.2002;1:91-99.
• Whiteside JL, Whiteside JW. Acute bronchitis: a review of diagnosis and evidence-based management. Prim Care Update for Ob/Gyns.2002;9:105-109.
• Whiteside JL, Walters M. Urinary incontinence: an overview and its relation to female genital tract tumors. CME J Gynecol Oncol.2002;1:91-99.
• Utian WH. Low Dose ERT/HRT - Evaluating Clinical Efficacy. Female Patient 27, 42-43, 2002.
• Utian WH. HRT, Dose and BMI. Menopause Management 11 (Suppl. 1), 15-16, 2002
• Utian WH. Rapidly Changing Trends in Postmenopausal Hormone Therapy.
  Adolescent Gynecology, Reproduction, Menopause, 14, 225-226, 2002.
• Utian WH, Leonard, Davis AD, Vega R. Efficacy and safety of a new synthetic 10-component, modified release conjugated estrogens tablet for treatment of vasomotor symptoms in postmenopausal women. Fertil. Steril.. 3S, 76, S159, 2002. (Abstract)
• Utian WH, Janata JJ, Kingsberg SA, Schluchter MS and Hamilton JC. The Utian Quality of Life (UQOL) Scale: Development and validation of an instrument to quantify quality of life through and beyond menopause. MENOPAUSE 9, 402-409, 2002.
• Uyan (UYAR?) D, Takigawa N, Kennedy A, Markman M. Skillings J, Lee F. Lebwohl D, Bukowski R. Ganapathi R. Characterization of cell death mechanisms of BMS-310705, an epothilone derivative. Proc AACR. 2002;43:922.
• Uyar D, Takigawa N, Kennedy AW, Markman M, Lee F, Lebwohl D, Bukowski R, Ganapathy R. Apoptotic pathways regulating efficacy of the novel epothilone BMS-247550 in drug-resistant ovarian cancer. Gynecol Oncol. 2002;84:511.
• Visco A, Barber MD, Myers E. Early physician experience with laparoscopically assisted vaginal hysterectomy and rates of surgical complications and conversion to laparotomy. Am J Obstet Gynecol.2002;187(4):1008-1012.
• Wang X*, Falcone T, Attaran M, Goldberg JM, , Agarwal A, Sharma RK. Vitamin C and Vitamin E supplementation reduces oxidative stress induced embryo toxicity and improves Blastocyst Development Rates. Fertil Steril 2002;78:1272-1277.
• Wang, X., Goldberg, J.M., Falcone, T., Attaran, M., Agarwal, A., and Sharma, R.K. (2002): Vitamin C and vitamin E supplementation reduces oxidative stress induced embryo toxicity and improves blastocyst development rates. Fertil Steril 78:1272-1277.
• Xu Y. Sphingosylphosphorylcholine and lysophosphatidylcholine: G protein coupled receptors and receptor-mediated signal transduction. Biochem Biophy Acta 1582, 81-88, 2002.
• Xu Y, Xiao YJ, Baudhuin LM, Lu J, Hong G, Kim KS, Crisina KL, Song LS, Williams F, Elson P, Markman M, Belinson J. Unfolding the pathophysiological role of bioactive lysophospholipids. Curr Drug Targets Immune Endocr Metabol Disord, 2003 Mar;3(1):23-32.
• Zanotti, KM, Belinson JL. The diagnosis and management of genital human papillomavirus infection. Cleve Clin J Med, December 2002.

Publications-Abstracts

• Desai, N., and Goldfarb, J. 2005. Comparison of day 5 vs day 3 transfer outcomes and examination of embryo development in Global blastocyst medium. American Society of Reproductive Medicine, Oct. 15 – 19 Montreal, Canada
• Desai, N., J. Filipovitz, p.Singh, J. Beman and Goldfarb, J. 2005. Assessment of soluble HLA-G levels in Day 3 embryo culture media using a new ELISA kit. American Society of Reproductive Medicine, Oct. 15 – 19 Montreal, Canada
• Desai, N., and Goldfarb, J. 2005. Observations on Day 3 embryo morphology and chromosomal status. American Society of Reproductive Medicine, Oct. 15 – 19 Montreal, Canada
• Desai, N., Szepticki, J and Goldfarb, J. 2005. Application of vitrification technology in the iVF Lab: Preliminary experience with human cleavage stage embryos, blastocysts and oocytes vitrified on cryoloops. American Society of Reproductive Medicine, Oct. 15-19 Montreal, Canada
• Desai, N., Szepticki, J and Goldfarb, J. 2005. Does addition of hyaluron to the freezing medium offer any benefit with either slow freeze protocol or alternatively with vitrification? American Society of Reproductive Medicine, Oct. 15 – 19 Montreal, Canada
• Desai, N., Kattal, N, Nowlis,E and Goldfarb, J. 2004 . Comparison of pronuclear morphology and outcomes after ICSI with frozen epididymal and testicular sperm. . American Society of Reproductive Medicine, Oct. 16-20 Philadelphia, PA
• Desai, N., Kattal, N, Szepticki, J and Goldfarb, J. 2004 . Coculture and its effect on embryonic apoptosis. American Society of Reproductive Medicine, Oct. 16 – 20 Philadelphia, PA
• Desai, N., Culler, C and Goldfarb, J. 2004 . Cryopreservation of single sperm from epididymal and testicular samples on cryoloops: preliminary case report. American Society of Reproductive Medicine, Oct. 16 – 20 Philadelphia, PA
• Desai, N., Szepticki, J and Goldfarb, J. 2004 . Clinical experience with co-culture using a novel human endometrial cell line and Transwell chambers to promote embryo development without cell contact. American Society of Reproductive Medicine, Oct. 16-20 Philadelphia, PA
• Desai, N. and Goldfarb, J. 2004. Examination of frozen cycles with replacement of a single thawed blastocyst. American Society of Reproductive Medicine, Oct. 16 – 20 Philadelphia, PA
• Desai, N., Lawson, J. and Goldfarb. 2003. Coculture of embryos with novel human endometrial cell line in Trans well dishes promotes embryo development without cell contact. American Society of Reproductive Medicine, Oct. 11–15 San Antonio,TX
• Desai, N., Blackmon, H. and Goldfarb, J. 2003. Single sperm cryopreservation on cryoloops: an alternative to hamster zona for cryopreservation of individual spermatozoa. American Society of Reproductive Medicine, Oct. 11–15 San Antonio,TX
• Desai, N., Szepticki-Lawson, J. and Goldfarb. 2003. Coculture of embryos with novel human endometrial cell line in Trans well dishes promotes embryo development without cell contact. American Society of Reproductive Medicine, Oct. 11–15 San Antonio,TX
• Desai, N., Blackmon, H. and Goldfarb, J. 2003. Can vitrification on cryoloops be used effectively for cryopreservation of day 3 cleavage stage embryos? American Society of Reproductive Medicine, Oct. 11–15 San Antonio,TX
• Desai, N., Kattal, N and Goldfarb, J. 2003. Examination of pronuclear patterns in a cohort of embryos selected for transfer on the basis of Day 3 embryos score. American Society of Reproductive Medicine, Oct. 11–15 San Antonio,TX
• Desai, N., Kattal, N, J. Lawson and Goldfarb, J. 2003 Can in vitro culture systems and media modulate apoptosis? American Society of Reproductive Medicine, Oct. 11–15 San Antonio,TX
• Desai, N. 2002. IVF laboratory; designed for success. Cleveland Clinic Fertility Perspectives
• Desai, N. Austin, C, Peskin, B., Lisbona, H and Goldfarb, J. 2001. Elective transfer of two embryos o Day 3 can give high implantation rates: comparison of Day 3 vs Day 5 transfers. American Society of Reproductive Medicine, Oct. 12 –17 Seattle, Wa
• Desai, N., Lawson, J. and Goldfarb. 2000 . Effect of culture regimen on blastocyst development,cell number and differentiation:comparison of commercial blastocyst culture media to coculture on Vero cell monolayers. American Society of Reproductive Medicine, Oct 21– 26 San Diego ,CA
• Desai, N., Lawson, J. and Goldfarb. 2000 . Effect of growth factor supplementation on blastocyst development in sequential human blastocyst culture medium. American Society of Reproductive Medicine, Oct. 21 – 26 San Diego ,CA
• Desai, N., Gindlesperger,V., Loeb, A and Goldfarb, J. 1999. Human frozen blastocyst transfer: pre and post-thaw morphology and patient parameters associated with positive outcomes. American Society of Reproductive Medicine, Sept. 25 – 30 Toronto, Canada
• Desai, N. , Goldstein, J. and Goldfarb,J 1999. Morphologic evaluation of human embryos and derivation of an embryo quality scoring system specific for Day 3 embryos., American Society of Reproductive Medicine, Sept. 25 – 30 Toronto, Canada
• Desai, N., Lawson, J. and Goldfarb, J. 1999. Comparison of ICM/ trophectoderm development in blastocysts arising from different in vitro culture regimens: effect of FGF-4, LIF and a growth factor cocktail. American Society of Reproductive Medicine, Sept. 25 – 30 Toronto , Canada
• Sawatsri,S, Razdan, R, Desai, N, Rock, J and Sidell, N. Retinoic acid suppresses interleukin-6 transcription in human endometrial cells. Society for Gynecological Investigations March 1999 Atlanta, Georgia
• Sawastri S, Razdan R, Desai, N and Sidell, N. Retinoid regulation of interleukin-6 in human endometrial cells. Society for Gynecological Investigations March 1998 Atlanta, Georgia
• Gill K, Mantione J, Desai N, Sidell N and Tekmal R. Role of colony stimulating factor-1 in endometrial cell growth. Soc. Gyn. Invest. March 1998. Abstract.
• Desai N, Lawson, J and Goldfarb, J. Assessment of growth factor effects on post-thaw development of cryopreserved morula to the blastocyst stage. Fertil. Steril. 1998; Abstract
• Desai N, Glavan, D and Goldfarb, J. A convenient technique for cryopreservation of micro quantities of sperm. N. Desai, D. Glavan and J. Goldfarb. Fertil. Steril., 1998 Abstract
• Desai N, Kinzer D, Thompson E, Loeb A and Goldfarb, J. 1997 Cryopreservation of morula stage embryos: post-thaw development in different culture systems. American Society of Reproductive Medicine Abstract.
• Desai, N., Kinzer, D, Loeb, A and Goldfarb, J . 1996. Use of synthetic serum substitute and alpha minimum essential medium for the extended culture of human embryos to the blastocyst stage. American Society of Reproductive Medicine, Nov. 2 – 6 Boston, MA
• Desai, N., Scarrow, M, Kinzer, D, and Goldfarb, J. 1996. Design of a new embryo culture system using human extracellular matrix and interleukin-6. American Society of Reproductive Medicine, Nov. 2 – 6 Boston, MA
• Desai, N., Kinzer, D, Scarrow, M, Hunt, P and Goldfarb, J . 1996. Confocal laser image analysis of growth factor cytokine expression by late cleavage and blastocyst stage human embryos. American Society of Reproductive Medicine, Nov. 2 – 6 Boston, MA
• Desai N, and Goldfarb, J. 1995. Quantification of LIF and growth factor secretion by Vero cell co-cultures American Society of Reproductive Medicine .Oct 7 – 12, Seattle ,Washington.
• Desai N, and Goldfarb, J. 1995 . Growth factor secretion by an emrbyotrophic endometrial cell line. Society of Reproductive Medicine .Oct 7 – 12, Seattle ,Washington.
• Desai, N., Sheean,D Austin, C, Peskin, B., Lisbona, H and Goldfarb, J. 1993. Clinical experience with Plasmanate as a protein supplement in IVF culture media: a retrospective study. American Society of Reproductive Medicine, Nov. 5 – 10 San Antonio, TX